Is Pfizer Inc. Stock (PFE) Overbought or Oversold?
RSI analysis computed from PFE's daily closing prices · Data through October 15, 2026
As of October 15, 2026, PFE’s 14-day RSI is 68.2, inside the neutral 30–70 band — neither overbought nor oversold by the conventional thresholds.
RSI-14 Scale
PFE reads 68.2 on the 0–100 scale.
The Supporting Picture
vs 50-Day MA
+5.8%
MA: $27.90
vs 200-Day MA
+12.6%
MA: $26.22
From 52-Wk High
0.0%
High: $29.43
Volume vs 20-Day Avg
-35%
Avg: 21.8M shares
The 50-day average is currently above the 200-day average, which technicians read as a longer-term uptrend backdrop for the RSI reading above.
What's Behind the Reading
October 15, 2026Pfizer Inc. currently registers a neutral momentum posture, despite its RSI-14 reading of 68.23. This higher RSI value reflects recent positive price action, as the stock is trading 5.5% above its 50-day moving average and is at its 52-week high. The upward movement follows the company's Q2 2026 earnings report on August 4, 2026, where Pfizer exceeded analyst expectations for earnings per share. Since that earnings announcement, the stock has experienced a notable upward drift, gaining 15.0%. This sustained positive momentum has contributed to the elevated RSI, indicating strong buying interest in the recent period.
Recent Overbought / Oversold Episodes
How PFE behaved the last few times RSI left the neutral band — including its return over the 5 trading days after each episode ended.
| Episode | Period | Next 5 Days |
|---|---|---|
| overbought | September 2, 2026 | -4.8% |
| overbought | August 25, 2026 | +0.0% |
| overbought | August 19, 2026 | +0.2% |
| oversold | July 1, 2026 | +1.5% |
Past behavior does not predict future results — small sample sizes especially.
Frequently Asked Questions
Is Pfizer Inc. (PFE) overbought right now?
What is RSI (Relative Strength Index)?
Is an overbought stock a sell signal?
How often is this page updated?
Where does this data come from?
Methodology
The verdict on this page is mechanical: we compute the 14-day Relative Strength Index with Wilder’s smoothing from PFE’s daily closing prices, and apply the conventional thresholds — above 70 is overbought, below 30 is oversold. Moving averages, the 52-week range, and volume comparisons come from the same price history.
Indicators are recomputed after every market close. The AI commentary adds context from current news via grounded search, but never changes the computed verdict. Note: closes are as-traded; a stock split would distort readings for a few weeks until the window rolls past it.
Not Financial Advice
This page is for education and information only. Indicators are mechanical calculations, AI commentary can contain errors, and nothing here is a recommendation to buy or sell any security. Do your own research and consider consulting a qualified financial advisor. See our full disclaimer.
Keep Digging on PFE
Pfizer Inc. Overview
Price, chart, analysis & financials
PFE: Why Is It Moving?
Updated daily
PFE: Price Prediction
Updated daily
PFE: Undervalued or Overvalued?
Updated daily
Same question, Healthcare peers